European Commission completes current cycle of pay-for-delay probes with fines imposed on Teva and Cephalon

Published date08 December 2020
Subject MatterPay-For-Delay,European Commission,EU,TFEU,Generic Drugs,Pharmaceutical Patents,Teva Pharmaceuticals,Pharmaceutical Industry
AuthorThomas Masterman
Law FirmAllen & Overy LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT